IP Library › Patent Application 19538076
Patent Application Utility
App. No. 19/538,076 · Confirmation No. 3962

DOSING AND ADMINISTRATION OF RECOMBINANT L-ASPARAGINASE

Docketed New Case - Ready for Examination View Publication ↗
⬇ PDF
 Code Description Pages PDF
2026-06-11 NTC.PUB Notice of Publication 1 View
2026-03-05 APP.FILE.REC Filing Receipt 3 View
2026-03-05 WFEE Fee Worksheet (SB06) 1 View
2026-03-05 WELCOME.LET Welcome Letter from USPTO Director and Deputy Director 1 View
2026-02-17 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2026-02-17 CRFE Sequence Listing in Computer Readable Format, No errors found 5 View
2026-02-12 SPEC Specification — View
2026-02-12 DRW Drawings-only black and white line drawings 49 View
2026-02-12 TRNA Transmittal of New Application 2 View
2026-02-12 ADS Application Data Sheet 9 View
2026-02-12 TRAN.LET Transmittal Letter 3 View
2026-02-12 PA.. Power of Attorney 1 View
2026-02-12 OATH Oath or Declaration filed 3 View
2026-02-12 SPEC Specification 128 View
2026-02-12 CLM Claims 2 View
2026-02-12 ABST Abstract 1 View
2026-02-12 N417 Electronic Filing System Acknowledgment Receipt 3 View
2026-02-12 N417.PYMT Electronic Fee Payment 2 View
2026-02-12 DRW.SUPP Drawings-black and white line and/or other drawings — View
2026-02-12 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
2026-02-12 SEQ.XML Sequence Listing (XML File) 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
19/538,076
Filed
2026-02-12
Pub. No.
US20260158122A1
Art Unit
OPAP